EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of hyaluronic acid and butyroyl glutathione in the management of glaucoma-related ocular surface disease: a prospective, interventional, double-blind, cross-over post market study

Gabriele Gallo Afflitto, Marialaura Fanelli, Vita Petrone, Rossella Chirico, Francesca Ceccarelli, Alessio Martucci, Antonella Minutolo, Francesco Aiello, Enrico Garaci, Claudia Matteucci, Carlo Nucci

Frontiers in Pharmacology · 05.06.2026 · 17

DOI: 10.3389/fphar.2026.1780815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 05.06.2026. Verfasst von Gabriele Gallo Afflitto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Unit, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To evaluate the efficacy of a novel eye drop formulation containing hyaluronic acid (0.2%) and butyroyl-glutathione (GSHC4, 0.4%) in glaucoma-associated ocular surface disease (G-OSD), and to explore putative mechanisms of action through in vitro assays of corneal epithelial wound healing and cytokine modulation under basal, inflammatory, and oxidative stress conditions.

Methods

In this preliminary, hypothesis-generating, prospective, double-blind, cross-over study, 16 patients with glaucoma or ocular hypertension and coexisting dry eye symptoms were randomized to receive either HA alone or HA + GSH-C4 for 4 weeks, separated by a 1-week washout. Clinical endpoints included the Ocular Surface Disease Index (OSDI), FACES scale, tear film break-up time (TFBUT), Schirmer test, and NEI fluorescein staining. Tear cytokines were quantified at multiple timepoints. In vitro, human corneal epithelial cells underwent scratch-wound assays and cytokine profiling.

Results

Fifteen of sixteen patients completed the study. HA + GSH-C4 significantly improved OSDI (p < 0.001), FACES scores (p = 0.012), TFBUT (p < 0.001), and NEI-SS (p < 0.001) compared with HA alone. No treatment-related adverse events were observed. Tear cytokine analysis revealed a reversible treatment-specific elevation of selected mediators (e.g., IFN-γ, IL-12p70) consistent with a controlled pro-repair response. The HA + GSH-C4 accelerated epithelial wound closure and selectively suppressed MCP-1 across all tested conditions.

Discussion

The HA + GSH-C4 formulation improved G-OSD symptoms and ocular surface stability, accompanied by a dynamic cytokine response in tears. These findings support its clinical utility and suggest a dual mechanism involving barrier restoration and modulation of ocular surface immune responses.

Schlagwörter

Stichwörter der Autor:innen

cytokinesdry eye syndromesglaucomaglutathionelubricant eye dropswound healing

Autor:innen und Institutionen

  • Ophthalmology Unit, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
  • Microbiology and Clinical Microbiology, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Casa di cura San Raffaele, Sulmona, L'Aquila, Italy.

Zitieren

APA

Gallo Afflitto, G., Fanelli, M., Petrone, V., Chirico, R., Ceccarelli, F., Martucci, A., Minutolo, A., Aiello, F., Garaci, E., Matteucci, C., & Nucci, C. (2026). Efficacy of hyaluronic acid and butyroyl glutathione in the management of glaucoma-related ocular surface disease: a prospective, interventional, double-blind, cross-over post market study. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1780815

Vancouver

Gallo Afflitto G, Fanelli M, Petrone V, Chirico R, Ceccarelli F, Martucci A, et al. Efficacy of hyaluronic acid and butyroyl glutathione in the management of glaucoma-related ocular surface disease: a prospective, interventional, double-blind, cross-over post market study. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1780815

BibTeX
@article{GalloAfflitto2026,
  author = {Gallo Afflitto, Gabriele and Fanelli, Marialaura and Petrone, Vita and Chirico, Rossella and Ceccarelli, Francesca and Martucci, Alessio and Minutolo, Antonella and Aiello, Francesco and Garaci, Enrico and Matteucci, Claudia and Nucci, Carlo},
  title = {Efficacy of hyaluronic acid and butyroyl glutathione in the management of glaucoma-related ocular surface disease: a prospective, interventional, double-blind, cross-over post market study},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1780815}
}
Kostenlos starten →